Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. uri icon

authors

  • Lam, Phillip H
  • Fletcher, Ross D
  • Arundel, Cherinne
  • Blackman, Marc R
  • Adamopoulos, Chris
  • Kanonidis, Ioannis E
  • Aban, Inmaculada B
  • Patel, Kanan
  • Aronow, Wilbert S
  • Allman, Richard M
  • Anker, Stefan D
  • Dooley, Daniel J
  • Pitt, Bertram
  • Ahmed, Ali
  • Fonarow, Gregg C
  • Butler, Javed
  • Bhatt, Deepak L
  • Filippatos, Gerasimos S
  • Deedwania, Prakash
  • Daniel E. Forman, MD
  • White, Michel

publication date

  • October 5, 2017